Optiray 320 Alternatives Compared
Optiray 320 (ioversol) | Omnipaque 350 (iohexol) | Iohexol |
|
---|
Optiray 320 (ioversol) | Omnipaque 350 (iohexol) | Iohexol |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Cerebral Arteriography, Body Imaging, Coronary Arteriography, Head Imaging, Intra-arterial Digital Subtraction Angiography, Intravenous Digital Subtraction Angiography, Intravenous... View more |
Prescription only
Prescribed for Angiocardiography, Body Imaging, Aortography, Arthrography, Cerebral Arteriography, Cystourethrography, Digital Subtraction Angiography, Gastrointestinal Tract Examination, Head... View more |
Prescription only
Prescribed for Angiocardiography, Body Imaging, Aortography, Arthrography, Cerebral Arteriography, Cystourethrography, Digital Subtraction Angiography, Gastrointestinal Tract Examination, Head... View more |
Related suggestions Body Imaging
Head Imaging
Visceral Arteriography
|
|||||||||||||||
More about Optiray 320 (ioversol) | More about Omnipaque 350 (iohexol) | More about Iohexol | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Optiray 320 has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Omnipaque 350 has an average rating of 7.0 out of 10 from a total of 4 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 0% reported a negative effect. |
Iohexol has an average rating of 3.2 out of 10 from a total of 11 ratings on Drugs.com. 11% of reviewers reported a positive effect, while 67% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Optiray 320 prices |
View all Omnipaque 350 prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
Brand Names | ||||||||||||||||||
Other ioversol brands include: Optiray 240, Optiray 300, Optiray 350 | Other iohexol brands include: Omnipaque 12, Omnipaque 140, Omnipaque 180, Omnipaque 180 Redi-Unit, Omnipaque 210, Omnipaque 240, Omnipaque 240 Redi-Unit, Omnipaque 300, Omnipaque 9, Omnipaque Flexipak, Oraltag View more | Omnipaque 12, Omnipaque 140, Omnipaque 180, Omnipaque 180 Redi-Unit, Omnipaque 210, Omnipaque 240, Omnipaque 240 Redi-Unit, Omnipaque 300, Omnipaque 350, Omnipaque 9, Omnipaque Flexipak, Oraltag View more | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
12 hours |
12 hours |
12 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 148 drugs are known to interact with Optiray 320:
|
A total of 325 drugs are known to interact with Omnipaque 350:
|
A total of 325 drugs are known to interact with Iohexol:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.